{"schema_version":"1","generated_at":"2026-11-08T01:11:01.024Z","data_as_of":null,"url":"https://www.findmykol.com/kol/maria-delioukina","json_url":"https://www.findmykol.com/kol/maria-delioukina/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"maria-delioukina","name":"Maria Delioukina","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Pfizer","institution_url":"https://www.findmykol.com/institution/pfizer","city":"West Hollywood","state":"CA","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1023035078","orcid":"0009-0005-6827-7502","openalex":"A5003640697"},"summary":"Maria Delioukina is an Oncology physician affiliated with Pfizer. OpenAlex indexes 72 publications with 1,559 citations (h-index 17); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":72,"cited_by_count":1559,"h_index":17,"latest_activity_year":2025,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT00865969","title":"Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma","phase":"PHASE2","status":"COMPLETED","role":"Overall official","sponsor":"Spectrum Pharmaceuticals, Inc","source_url":"https://clinicaltrials.gov/study/NCT00865969","trial_url":"https://www.findmykol.com/trial/NCT00865969"}],"source":"trials"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"First-in-Human Phase I/IIa Study of the First-in-Class CDK2/4/6 Inhibitor PF-06873600 Alone or with Endocrine Therapy in Patients with Breast Cancer","year":2025,"journal":"Clinical Cancer Research","source_url":"https://doi.org/10.1158/1078-0432.ccr-24-2740","status":"verified"},{"title":"Abstract P5-07-28: The next-generation CDK4-selective inhibitor atirmociclib (PF-07220060) in combination with letrozole as first-line treatment in patients with HR+/HER2+ metastatic breast cancer","year":2025,"journal":"Clinical Cancer Research","source_url":"https://doi.org/10.1158/1557-3265.sabcs24-p5-07-28","status":"verified"},{"title":"First-in-human, open-label, Phase 1 study of a novel CD30-directed antibody-drug conjugate with a topoisomerase 1 inhibitor payload, PF-08046044 (35C), in patients with Relapsed/Refractory lymphomas: Updated safety, PK, preliminary efficacy and ctdna analysis from dose escalation","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2025-155","status":"verified"},{"title":"First-in-human phase 1/2a study of the first-in-class, next-generation CDK4-selective inhibitor PF-07220060 + endocrine therapy (ET): Updated safety data in patients with HR+/HER2− mBC.","year":2024,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2024.42.16_suppl.3108","status":"verified"},{"title":"184MO First-in-human phase I/IIa study of the first-in-class, next-generation CDK4-selective inhibitor PF-07220060 in combination with endocrine therapy (ET) in patients (pts) with HR+/HER2− metastatic breast cancer (mBC) who progressed on prior CDK4/6 inhibitors (CDK4/6i): Safety and efficacy update","year":2024,"journal":"ESMO Open","source_url":"https://doi.org/10.1016/j.esmoop.2024.103206","status":"verified"}],"source":"works"},"contact":{"address_1":"8700 BEVERLY BLVD","address_2":"AC1078","city":"West Hollywood","state":"CA","zip":"900481804","phone":"310-423-1160","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1023035078","source":"identity"},"similar":[{"name":"Johanna Bendell","slug":"johanna-bendell","institution":"Pfizer","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/johanna-bendell","json_url":"https://www.findmykol.com/kol/johanna-bendell/profile.json"},{"name":"Yoshiko Umeyama","slug":"yoshiko-umeyama","institution":"Pfizer","url":"https://www.findmykol.com/kol/yoshiko-umeyama","json_url":"https://www.findmykol.com/kol/yoshiko-umeyama/profile.json"},{"name":"Lídia Sànchez-Riera","slug":"lidia-sanchez-riera","institution":"Pfizer","url":"https://www.findmykol.com/kol/lidia-sanchez-riera","json_url":"https://www.findmykol.com/kol/lidia-sanchez-riera/profile.json"},{"name":"Philip Dormitzer","slug":"philip-dormitzer","institution":"Pfizer","specialty":"Internal Medicine","url":"https://www.findmykol.com/kol/philip-dormitzer","json_url":"https://www.findmykol.com/kol/philip-dormitzer/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2013-11-12","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"}},"methodology_url":"https://www.findmykol.com/about#methodology"}